Cite
HARVARD Citation
Almeida, L. et al. (2023). FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral diseases. pp. 649-660. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Almeida, L. et al. (2023). FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral diseases. pp. 649-660. [Online].